Oral colonization by Candida albicans

被引:213
作者
Cannon, RD
Chaffin, WL
机构
[1] Univ Otago, Fac Dent, Dept Oral Sci & Orthodont, Dunedin, New Zealand
[2] Texas Tech Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Lubbock, TX 79430 USA
关键词
Candida albicans; colonization; adherence; candidiasis;
D O I
10.1177/10454411990100030701
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Candida albicans is a commensal yeast normally present in small numbers in the oral flora of a large proportion of humans. Colonization of the oral cavity by C. albicans involves the acquisition and maintenance of a stable yeast population. Micro-organisms are continually being removed from the oral cavity by host clearance mechanisms, and so, in order to survive and inhabit this eco-system, C. albicans cells have to adhere and replicate. The oral cavity presents many niches for C. albicans colonization, and the yeast is able to adhere to a plethora of ligands. These include epithelial and bacterial cell-surface molecules, extracellular matrix proteins, and dental acrylic. In addition, saliva molecules, including basic proline-rich proteins, adsorbed to many oral surfaces promote C. albicans adherence. Several adhesins present in the C. albicans cell wall have now been partially characterized. Adherence involves lectin, protein-protein, and hydrophobic interactions. As C. albicans cells evade host defenses and colonize new environments by penetrating tissues, they are exposed to new adherence receptors and respond by expressing alternative adhesins. The relatively small number of commensal Candida cells in the oral flora raises the possibility that strategies can be devised to prevent oral colonization and infection. However, the variety of oral niches and the complex adherence mechanisms of the yeast mean that such a goal will remain elusive until more is known about the contribution of each mechanism to colonization.
引用
收藏
页码:359 / 383
页数:25
相关论文
共 265 条
[41]  
COX F, 1983, J LAB CLIN MED, V102, P960
[42]  
COX F, 1986, J MED VET MYCOL, V24, P121
[43]  
CRITCHLEY IA, 1987, J GEN MICROBIOL, V133, P629
[44]  
CRITCHLEY IA, 1987, J GEN MICROBIOL, V133, P637
[45]   Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues [J].
Darouiche, RO .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :259-272
[46]   SYSTEMIC FLUCONAZOLE THERAPY AND INVITRO ADHESION OF CANDIDA-ALBICANS TO HUMAN BUCCAL EPITHELIAL-CELLS [J].
DARWAZEH, AMG ;
LAMEY, PJ ;
LEWIS, MAO ;
SAMARANAYAKE, LP .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1991, 20 (01) :17-19
[47]  
DAVIDSON S, 1984, MYCOPATHOLOGIA, V85, P171
[48]   EXPRESSION OF CANDIDA-ALBICANS SAP1 AND SAP2 IN EXPERIMENTAL VAGINITIS [J].
DEBERNARDIS, F ;
CASSONE, A ;
STURTEVANT, J ;
CALDERONE, R .
INFECTION AND IMMUNITY, 1995, 63 (05) :1887-1892
[49]   Non-insulin-dependent diabetes mellitus as a risk factor for denture stomatitis [J].
DorockaBobkowska, B ;
BudtzJorgensen, E ;
Wloch, S .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1996, 25 (08) :411-415
[50]  
Edgerton M, 1996, Int J Oral Maxillofac Implants, V11, P443